How many units of Endoluten should I draw?

It depends on your vial size, BAC water, and dose. For a 10mg vial with 0mL BAC water, a beginner dose of 10mg is typically 0 units on a U-100 syringe. Use the calculator above for your exact numbers.

How much BAC water should I add to Endoluten?

The standard amount is 0mL of bacteriostatic water for a 10mg vial. More water gives a more dilute solution — easier to measure small doses. Less water means fewer injections per vial. Adjust the BAC water slider in the calculator to see how it changes your syringe units.

How long does a Endoluten vial last?

At a beginner dose of 10mg daily, a 10mg vial lasts about 1000 doses. The calculator shows exact doses per vial for your selected tier.

What syringe should I use for Endoluten?

Most people use a U-100 insulin syringe (1mL / 100 units). For very small doses, a U-50 or U-30 syringe gives better precision. The calculator adjusts units automatically for whichever syringe you pick.

Endoluten Dosage Calculator

Anti-AgingOralResearch~2-4 hours half-life

Endoluten is a pineal gland peptide bioregulator developed as part of Vladimir Khavinson's decades-long research program into organ-specific peptide therapy.

Normalizes melatonin synthesis and circadian rhythm in the pineal glandRestores nighttime melatonin secretion in elderly subjects with age-related declineContains AEDG peptide associated with telomerase activation and geroprotectionContains EDR peptide with demonstrated neuroprotective and antioxidant properties2 weeks on / 12 weeks off

Vial Size

BAC Water (mL)

Dosing Level

10mcg · Daily

Custom Dose (mcg) — optional

Syringe Type

0.0 units

100 units (1mL)

Concentration

mcg/mL

Draw Volume

< 0.001

Syringe Units

< 0.1

units

Doses / Vial

doses

Summary: Add 0mL BAC water to your 10mg vial. Draw to < 0.1 units on a U-100 syringe for a 10mcg dose. This vial will last 0 doses.

Cycle Planner

Cycle Length (weeks)

Price Per Vial ($) — optional

Oral. Typical beginner frequency: daily.

Endoluten Pharmacokinetics

Pharmacokinetics — Active Dose Over Time

t½ = ~2-4 hours (estimated, polypeptide complex)

After 1 half-life (3h): 50% remainsAfter 2 half-lives (6h): 25% remainsAfter 3 half-lives (9h): 12.5% remains

At a 20mcg dose: 50% = 10mcg remaining after 3h. Recommended frequency: Daily.

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.

Endoluten Dosing Protocol

Level	Dose / Injection	Frequency
Beginner	10mg	Daily
Moderate	20mg	Daily
Aggressive	20mg	2x Daily

Note: Endoluten (A-8) is a polypeptide bioregulator complex extracted from the pineal gland of young calves, containing short-chain peptides including EDR (Glu-Asp-Arg, also known as Pinealon) and AEDG (the active sequence in Epithalon). Taken orally as capsules, typically 1-2 capsules daily for 10-day courses repeated every 3-6 months. Each capsule contains approximately 10 mg of the purified peptide complex.

About Endoluten

Endoluten is a pineal gland peptide bioregulator developed as part of Vladimir Khavinson's decades-long research program into organ-specific peptide therapy. It's produced by acid extraction and chromatographic purification of pineal tissue from calves under 12 months old. Mass spectrometry has confirmed the presence of AEDG tetrapeptide (the synthetic version of which is Epithalon) among its bioactive components. The preparation also contains the tripeptide EDR (Glu-Asp-Arg), independently studied for neuroprotective properties. Russian gerontological research spanning over 20 years has shown that pineal peptide preparations can restore nighttime melatonin secretion in elderly subjects and normalize the hormone's circadian rhythm. A landmark 6-8 year follow-up study of 266 elderly participants found that combined pineal and thymic peptide treatment reduced mortality rates up to 4.1-fold compared to controls. While Endoluten's clinical evidence is concentrated in Russian-language literature, the underlying peptide components (AEDG and EDR) have been characterized in international peer-reviewed journals.

View full Endolutenguide →Add to schedule →